Literature DB >> 29650692

MicroRNA-Mediated Therapy Modulating Blood-Brain Barrier Disruption Improves Vascular Cognitive Impairment.

Kensuke Toyama1,2, Joshua M Spin3,2, Alicia C Deng3,2, Ting-Ting Huang4, Ke Wei2, Markus U Wagenhäuser3,2, Takuya Yoshino3,2, Huy Nguyen4, Joscha Mulorz3,2, Soumajit Kundu2, Uwe Raaz3,2, Matti Adam3,2, Isabel N Schellinger3,2, Ann Jagger3,2, Philip S Tsao1,2.   

Abstract

OBJECTIVE: There are currently no effective treatments for the prevention of dementia associated with vascular cognitive impairment. MicroRNAs regulate gene expression at the post-transcriptional level and play key roles in vascular disorders. TNFα (tumor necrosis factor-α) regulates blood-brain barrier breakdown through modification of cerebral tight junctions. Here, we sought key TNFα-responsive microRNAs that might influence blood-brain barrier breakdown via cerebral tight junction disruption in vascular cognitive impairment. APPROACH AND
RESULTS: Using a mouse model of vascular cognitive impairment, chronic cerebral hypoperfusion within the white matter was induced with bilateral common carotid artery stenosis (BCAS) surgery. TNFα gene expression was increased in white matter post-BCAS surgery, and TNFα stimulation decreased claudin-5, ZO-1 (tight-junction protein 1), and occludin gene expression in murine brain endothelial cells. In silico analysis predicted 8 candidate microRNAs as regulators of claudin-5, ZO-1, and occludin gene expression. Of these, only miR-501-3p was upregulated by TNFα in vitro and was upregulated in the white matter after BCAS surgery. Further, miR-501-3p directly bound to the 3'-untranslated region of human ZO-1 and downregulated transendothelial electric resistance. In vivo administration of a locked nucleic acid -modified antisense oligonucleotide versus miR-501-3p suppressed BCAS-induced reduction of ZO-1 gene expression and blood-brain barrier disruption within the white matter and significantly ameliorated working memory deficits after BCAS surgery.
CONCLUSIONS: We here provide the first evidence that the TNFα-miR-501-3p-ZO-1 axis plays an important role in the pathogenesis of cerebral hypoperfusion-induced working memory deficits and white matter lesions, as a result of blood-brain barrier breakdown via tight junction disruption. Therapeutic manipulation of miR-501-3p holds promise for limiting vascular cognitive impairment progression.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  blood–brain barrier; dementia; microRNA; tight junction

Mesh:

Substances:

Year:  2018        PMID: 29650692     DOI: 10.1161/ATVBAHA.118.310822

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  31 in total

1.  Transcriptome Sequencing Identifies Potential Biomarker for White Matter Lesions Diagnosis in the Hypertension Population.

Authors:  Wendi Wang; Pei Sun; Fengyue Han; Chunjuan Wang; Yongxiang Wang; Xiang Wang; Lin Cong; Chuanqiang Qu
Journal:  Neurochem Res       Date:  2021-05-26       Impact factor: 3.996

2.  Identification of miRNA and Their Regulatory Effects Induced by Total Flavonoids From Dracocephalum moldavica in the Treatment of Vascular Dementia.

Authors:  Mimin Liu; Guangzhi Shan; Hailun Jiang; Li Zeng; Kaiyue Zhao; Yiran Li; Ghulam Md Ashraf; Zhuorong Li; Rui Liu
Journal:  Front Pharmacol       Date:  2021-12-06       Impact factor: 5.810

Review 3.  Blood-Brain Barrier Dysfunction and the Potential Mechanisms in Chronic Cerebral Hypoperfusion Induced Cognitive Impairment.

Authors:  WenQing Xu; Qingke Bai; Qiang Dong; Min Guo; Mei Cui
Journal:  Front Cell Neurosci       Date:  2022-06-16       Impact factor: 6.147

Review 4.  Annual Report on Sex in Preclinical Studies: Arteriosclerosis, Thrombosis, and Vascular Biology Publications in 2018.

Authors:  Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-12-23       Impact factor: 8.311

5.  MicroRNA predicts cognitive performance in healthy older adults.

Authors:  Joseph M Gullett; Zhaoyi Chen; Andrew O'Shea; Maisha Akbar; Jiang Bian; Asha Rani; Eric C Porges; Thomas C Foster; Adam J Woods; Francois Modave; Ronald A Cohen
Journal:  Neurobiol Aging       Date:  2020-08-03       Impact factor: 4.673

6.  Anfibatide Preserves Blood-Brain Barrier Integrity by Inhibiting TLR4/RhoA/ROCK Pathway After Cerebral Ischemia/Reperfusion Injury in Rat.

Authors:  Peng Gong; Rui Li; Hui-Yu Jia; Zheng Ma; Xiao-Yi Li; Xiang-Rong Dai; Sheng-Yong Luo
Journal:  J Mol Neurosci       Date:  2019-09-03       Impact factor: 3.444

Review 7.  Targeting Transcription Factor Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2) for the Intervention of Vascular Cognitive Impairment and Dementia.

Authors:  Tuo Yang; Feng Zhang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-15       Impact factor: 8.311

Review 8.  Targeting microRNAs to Regulate the Integrity of the Blood-Brain Barrier.

Authors:  Juntao Wang; Fang Xu; Xiaoming Zhu; Xianghua Li; Yankun Li; Jia Li
Journal:  Front Bioeng Biotechnol       Date:  2021-06-11

Review 9.  Development of Novel Therapeutics Targeting the Blood-Brain Barrier: From Barrier to Carrier.

Authors:  Jia Li; Meng Zheng; Olga Shimoni; William A Banks; Ashley I Bush; Jennifer R Gamble; Bingyang Shi
Journal:  Adv Sci (Weinh)       Date:  2021-06-03       Impact factor: 16.806

Review 10.  Impact of miRNA in Atherosclerosis.

Authors:  Yao Lu; Tanuja Thavarajah; Wenduo Gu; Jingjing Cai; Qingbo Xu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.